Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies

INTRODUCTION: The purpose of this retrospective study was to determine the clinical utility of serum HER2/neu in monitoring metastatic breast cancer patients undergoing trastuzumab-based therapy and to compare these results with those obtained using cancer antigen (CA) 15-3. We also sought to determ...

Descripción completa

Detalles Bibliográficos
Autores principales: Esteva, Francisco J, Cheli, Carol D, Fritsche, Herbert, Fornier, Monica, Slamon, Dennis, Thiel, Robert P, Luftner, Diana, Ghani, Farooq
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175054/
https://www.ncbi.nlm.nih.gov/pubmed/15987448
http://dx.doi.org/10.1186/bcr1020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175054/
https://www.ncbi.nlm.nih.gov/pubmed/15987448
http://dx.doi.org/10.1186/bcr1020

Ejemplares similares